Advertisement

Polymer Bulletin

, Volume 64, Issue 5, pp 459–469 | Cite as

Preparation and characterization of the poly(2-hydroxyethyl methacrylate)–salicylic acid conjugate

  • Roman JantasEmail author
  • Lucyna Herczyńska
Original Paper

Abstract

A new polymeric system containing hydrolysable ester bond linked to salicylic acid to be used for controlled drug release was synthesized. Poly(2-hydroxyethyl methacrylate) (PHEMA) functionalized with chloroacetate groups was obtained by the reaction between PHEMA and chloroacetyl chloride using the N,N-dimethylacetamide/5% lithium chloride system as a solvent and pyridine as a catalyst. The degree of substitution was calculated from the chlorine content and ranged from 32.2 to 98.1 mol.% depending on the ratio of chloroacetyl chloride to PHEMA. The coupling of salicylic acid to PHEMA functionalized with chloroacetate groups was carried out by the reaction between PHEMA and the sodium salt of salicylic acid. The structures of chloroacetylated PHEMA and PHEMA–salicylic acid conjugates were determined by means of FTIR, 1H-NMR and 13C-NMR spectra. The hydrolysis in the heterogeneous system of PHEMA–salicylic acid conjugates were performed in buffer solutions (pH 7.6 and 8.5) at 37 °C and showed that the release of the drug (sodium salicylate) from tablets was dependent on the hydrophilic character of conjugate as well as on the pH value of the medium.

Keywords

Polymer–drug conjugate Poly(2-hydroxyethyl methacrylate) Chloroacetylation Sodium salicylate Controlled release 

References

  1. 1.
    Ringsdorf JH (1975) Structure and properties pharmacologically active polymers. J Polym Sci Symp 51:135CrossRefGoogle Scholar
  2. 2.
    Mora M, Pato J (1990) Polymeric prodrugs, synthesis and hydrolytic behaviour of dextran-bound anticancer agents. Macromol Chem 191:1051CrossRefGoogle Scholar
  3. 3.
    Kim IS, Kim SH (2002) Development polymeric nanoparticulate drug delivery system: in vitro characterization of nanoparticles based on super-containing conjugates. Int J Pharm 245:67CrossRefGoogle Scholar
  4. 4.
    De Souza AJM, Schowen RL, Topp FM (2004) Poly(vinylpyrrolidone)-drug conjugate: synthesis and release mechanism. J Controlled Release 94:91CrossRefGoogle Scholar
  5. 5.
    Hoste K, De Winne K, Schacht E (2004) Polymeric prodrugs. Int J Pharm 277:119CrossRefGoogle Scholar
  6. 6.
    Hang R, Kratz F (2006) Polymer therapeutics: concepts and applications. Angew Chem Int Ed Engl 45:1198CrossRefGoogle Scholar
  7. 7.
    Babazadeh M (2006) Synthesis and study of controlled release of ibuprofen from the new acrylic type polymers. Int J Pharm 316:68CrossRefGoogle Scholar
  8. 8.
    Khandare J, Minko T (2006) Polymer-drug conjugates: progress in polymeric prodrugs. Prog Polym Sci 31:359CrossRefGoogle Scholar
  9. 9.
    Babazadeh M (2007) Synthesis, characterization and in vitro drug-release properties of 2-hydroxyethyl methacrylate copolymers. J Appl Polym Sci 104:2403CrossRefGoogle Scholar
  10. 10.
    Dvorak M, Kopečkova P, Kopeček J (1999) High-molecular weight HPMA copolymer-adriamycin conjugates. J Controlled Release 60:321CrossRefGoogle Scholar
  11. 11.
    Arranz F, Bejarano EM, Sanchez-Chaves M (1994) Poly(vinyl alcohol) functionalized by chloroacetate groups. Coupling of bioactive carboxylic acids. Macromol Chem Phys 195:3789CrossRefGoogle Scholar
  12. 12.
    Bonina FP, Motenegro L, Capraiis PD, Palagiano F, Trapani G, Liso G (1995) In vitro and in vivo evaluation of polyoxyethylene indomethacin ester as dermal prodrugs. J Controlled Release 34:223CrossRefGoogle Scholar
  13. 13.
    Sanchez-Chaves M, Arranz F, Diaz C (1989) Synthesis and characterization of 2-acetoxybenzoic acid-dextran ester conjugates. Macromol Chem 190:2391CrossRefGoogle Scholar
  14. 14.
    Sanchez-Chaves M, Arranz F, Diaz C (1989) Controlled release behaviour of 2-acetoxybenzoic acid-dextran conjugates. Macromol Chem Rapid Commun 10:431CrossRefGoogle Scholar
  15. 15.
    Won ChY, Chu ChCh, Yu T (1997) Synthesis of starch-based drug carrier for the control/release of estrone hormone. J Carbohydr Res 32:239Google Scholar
  16. 16.
    Bonina FP, Puglia C, Barbuzzi T, Capraiis PD, Palagiano F, Rimoli MG, Saija A (2001) In vitro and in vivo evaluation of polyoxyethylene ester as dermal prodrugs of ketoprofen, naproxen and diclofenac. Eur J Pharm Sci 14:123CrossRefGoogle Scholar
  17. 17.
    Davaran S, Hanaee J, Khosravi A (1999) Release of 5-amino salicylic acid from acrylic type polymeric prodrugs designed for colon-specific drug delivery. J Controlled Release 58:297CrossRefGoogle Scholar
  18. 18.
    Duarte AR, Costa MS, Simplicio AL, Cardoso M, Duarte CMM (2006) Preparation of controlled release microspheres using supercritical fluid technology for delivery of anti-inflammatory drugs. Int J Pharm 308:168CrossRefGoogle Scholar
  19. 19.
    Davaran S, Entezami A (1997) Acrylic type polymers containing ibuprofen and indomethacin with difunctional spacer group: synthesis and hydrolysis. J Controlled Release 47:41CrossRefGoogle Scholar
  20. 20.
    Kim SY, Shin IG, Lee YM, Cho CS, Sung YK (1998) Methoxy poly(ethylene glycol) and ε-caprolactone amphiphilic block copolymeric micelle containing indomethacin: II Micelle formation and drug release behaviours. J Controlled Release 51:13CrossRefGoogle Scholar
  21. 21.
    Davaran S, Entezami A (1998) Hydrophilic copolymers prepared from acrylic type derivatives of ibuprofen containing hydrolyzable thioester bond. Eur Polym J 34:187CrossRefGoogle Scholar
  22. 22.
    Chang CH, Sheu YM, Hu WP, Wang LF, Chen JS (1998) Synthesis and properties of copolymers 2-hydroxyethyl methacrylate-linked nonsteroidal antinflammatory agents with methacrylic acid. J Polym Sci Symp 36:1481Google Scholar
  23. 23.
    Zovko M, Zorc B, Lovrek M, Boneschenans B (2001) Macromolecular prodrugs IX Synthesis of polymer-fenoprofen conjugates. Int J Pharm 228:129CrossRefGoogle Scholar
  24. 24.
    Kim SY, Chung CW, Hwang SJ, Rhee YH (2005) Drug release from and hydrolytic degradation of a poly(ethylene glycol) grafted poly(3-hydroxyoctanoate). Int J Biol Macromol 36:84CrossRefGoogle Scholar
  25. 25.
    Merwe TVD, Boneschenans B, Zorc B, Breytenbach J, Zovko M (2002) Macromolecular prodrugs X Kinetics of fenoprofen release from PHEA-fenoprofen conjugate. Int J Pharm 241:223CrossRefGoogle Scholar
  26. 26.
    Omata K, Nozawa Y, Higashide F (1977) Drug released from cellulose acetic phthalate gel. J Appl Polym Sci 21:2009CrossRefGoogle Scholar
  27. 27.
    Harris FW (1984) Controlled release from polymers containing pendent bioactive substituents. In: Langer RS, Wise DL (eds) Medical application of controlled release. CRC, Boca Raton, FL, 103 ppGoogle Scholar
  28. 28.
    Levenfeld B, San Roman J, Madrug E (1990) Polymers with pharmacological activity: 2, Synthesis and free radical polymerization of an acrylic derivative of phenacetin. Polymer 31:160CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  1. 1.Department of Physical Chemistry of PolymersTechnical University of ŁódźLodzPoland

Personalised recommendations